37S0 Stock Overview
Engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Spineway SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.69 |
52 Week High | €840.00 |
52 Week Low | €0.56 |
Beta | 1.31 |
11 Month Change | -20.51% |
3 Month Change | n/a |
1 Year Change | -99.92% |
33 Year Change | -100.00% |
5 Year Change | -100.00% |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
37S0 | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | -34.9% | -0.5% | 0.9% |
1Y | -99.9% | 2.3% | 5.7% |
Return vs Industry: 37S0 underperformed the German Medical Equipment industry which returned 2.3% over the past year.
Return vs Market: 37S0 underperformed the German Market which returned 5.7% over the past year.
Price Volatility
37S0 volatility | |
---|---|
37S0 Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 4.2% |
Market Average Movement | 4.7% |
10% most volatile stocks in DE Market | 10.1% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 37S0's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 37S0's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 54 | Stephane Le Roux | www.spineway.com |
Spineway SA engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column. The company offers ayers rock, an anterior cervical interbody fusion cage; blue mountain, an anterior cervical interbody fusion plate; mont blanc, a posterior thoracolumbar pedicle screws; mont blanc baby, a pediatric growing rod system; mont blanc 3d+, a coplanar alignment system; posterior osteosynthesis systems; kili, an anterior lumbar interbody fusion cage; twin peaks plif posterior lumbar interbody fusion cages; twin peaks tlif transforaminal lumbar interbody fusion cages; and mont blanc mis, a mini-invasive thoracolumbar system. It also provides neve, a biomaterial bone substitute for bone regeneration; and cervical and lumbar prosthesis elastic spine pads.
Spineway SA Fundamentals Summary
37S0 fundamental statistics | |
---|---|
Market cap | €499.78k |
Earnings (TTM) | -€6.51m |
Revenue (TTM) | €11.36m |
0.0x
P/S Ratio-0.1x
P/E RatioIs 37S0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
37S0 income statement (TTM) | |
---|---|
Revenue | €11.36m |
Cost of Revenue | €8.89m |
Gross Profit | €2.46m |
Other Expenses | €8.97m |
Earnings | -€6.51m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -7.82 |
Gross Margin | 21.69% |
Net Profit Margin | -57.32% |
Debt/Equity Ratio | 13.5% |
How did 37S0 perform over the long term?
See historical performance and comparison